Urogenital atrophy refers to changes in the vagina and urethra due to declining estrogen levels in these tissues.
Risks & Causes
Urogenital atrophy typically occurs due to declining estrogen levels in menopause. However, decreased estrogen stimulation of urogenital tissue can also occur in premenopausal women.
Symptoms & Evaluation
Symptoms of urogenital atrophy include vaginal dryness, itching or irritation, pain with intercourse, recurrent urinary tract infections, urinary frequency and urgency, pale and thin vaginal skin, narrowing or shortening of the vagina and other anatomical changes.
Treatment Options
The most effective treatment for urogenital atrophy is low-dose vaginal estrogen replacement. This topical estrogen comes in a variety of preparations including a cream, suppository and intravaginal ring. It is important to be aware that low-dose vaginal estrogen replacement is NOT the same as systemic estrogen replacement therapy used to treat hot flashes and bone loss.